Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Duesseldorf, Germany, June 12, 2026 (GLOBE NEWSWIRE) -- IvyBears, the fast-growing children’s brand expanding into animated entertainment, has unveiled the official trailer for Episode 3 of its new...
-
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ: XELB), an industry-leading media and consumer products company specializing in building influencer led brands through social commerce...
-
WILMINGTON, Del., June 11, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video and AI technology research and development company, today announced that it has entered into...
-
60 Degrees Pharma licensed FSU technology for Australian Chestnut Extract production and plans FDA discussions before refiling its NDIN.
-
New Orleans, LA, June 09, 2026 (GLOBE NEWSWIRE) -- Loyola University New Orleans today announced that Wolf Pack Athletics has been accepted as a member of the Gulf South Conference (GSC), a Division...
-
WestGene’s established targeted LNP platform combined with Cartesian’s mRNA payload from Descartes-08 integrates two independently, clinically tested technologies for rapid clinical translation Plans...
-
AI Era Corp Enters into Agreement with BCII Enterprises to License Coupon and Super Coupon Technology Platform
-
AUTOMATIC SHARE PURCHASE PLAN London, 5 June 2026 – Endeavour Mining Plc (LEI: 529900NI5MXQ91GHXR07, LSE: EDV, TSX: EDV, OTCQX:EDVMF) (“the Company”) has re-entered into an Automatic Share...
-
– Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC platform — — Stipple Bio’s Pointillist Platform identifies...
-
Agios announces an agreement with Oscotec to license the exclusive global rights to cevidoplenib, a novel, next generation, oral SYK inhibitor